Fourteen-day bactericidal activity, safety, and pharmacokinetics of linezolid in adults with drug-sensitive pulmonary tuberculosis [PDF]
, 2020 Linezolid is increasingly used for the treatment of tuberculosis resistant to first-line agents, but the most effective dosing strategy is yet unknown.
Burger, Divan Aristo +9 more
core +1 more source
AN OVERVIEW ON TUBULARCULOSIS TREATMENT IN CURRENT SCENARIO [PDF]
, 2020 The causative agent of tuberculosis (TB) is Mycobacterium tuberculosis, which mainly infects lungs and causes severe, fever, weight loss, chest pain, etc. It is an extremely transmittable disease spreaded throughout the world as per the WHO.
BUDHORI, AMIT +3 more
core +1 more source
Hubungan Kadar Kalium dan Kadar Ureum Terhadap Jenis Obat Baru pada Pasien Tuberkulosis Resistan Obat (TB RO) [PDF]
The use of new types of drugs in RO TB patients will cause disturbances in the body's electrolytes, especially potassium levels, as well as disturbances in urea levels caused by the excretion of urea that is retained in the body.
Anggita, Sasha Marwah +2 more
core +1 more source
Бедаквилин в лечении лекарственно-устойчивого туберкулеза [PDF]
, 2021 Bedaquiline in the treatment of resistant tuberculosis.Scopul studiului s-a redus la elucidarea şi analiza asocierilor bedaquilinei (Bdq) cu preparatele antituberculoase de linia a II-a în tratamentul tuberculozei multudrodrezestentă şi cu ...
Bacinschi, Nicolae +6 more
core +1 more source
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis [PDF]
, 2018 Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in ...
Tiberi, S, Vjecha, MJ, Zumla, A
core +1 more source
Development and application of the direct mycobacterial growth inhibition assay: a systematic review [PDF]
Introduction: First described by Wallis et al. in 2001 for the assessment of TB drugs, the direct mycobacterial growth inhibition assay (MGIA) offers a tractable ex vivo tool measuring the combined influences of host immunity, strain virulence and ...
Fletcher, Helen +4 more
core +2 more sources
Treatment of Buruli ulcer: research, development, and repurposing of new therapeutics targeting Mycobacterium ulcerans [PDF]
Tese de doutoramento em Ciências da SaúdeMycobacterium ulcerans é o agente patogénico responsável pela Úlcera de Buruli, uma doença infeciosa tropical negligenciada.
Dominguez Enriquez, Juan Pablo
core
The Decrease in Antibiotic Funding [PDF]
, 2015 Tuberculosis (TB) is a bacterial disease treated with antibiotics. But because of the prevalence, nature, and lengthy treatment of the disease, TB is in need of new antibiotics.
Morgan, Gina
core +1 more source
Diseño de nuevos fármacos y nuevas dianas frente al mycobacterium tuberculosis [PDF]
, 2017 La tuberculosis es, hoy día, una amenaza para la salud en todo el mundo. A medida que las cepas de Mycobacterium tuberculosis han ido surgiendo y se han transformado en cepas resistentes, el fracaso del tratamiento es con demasiada frecuencia un hecho ...
Fernández Gil, Álvaro +1 more
core +1 more source
Multi-drug resistant tuberculosis in the Netherlands:Personalised treatment and outcome [PDF]
, 2016 Tuberculosis (TB) caused by bacilli that are resistant to the two major drugs, rifampicin and isoniazid is defined as Multi-Drug Resistant TB or MDRTB. MDRTB kills around 50% of people affected around the world.
van Altena, Richard
core +5 more sources